Drug Type AAV based gene therapy |
Synonyms AAV-BAG3 CNS program (Renovacor), AAV BAG3 (Renovacor) |
Target |
Mechanism BAG3 inhibitors(BAG molecular chaperone regulator 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Dilated | Preclinical | US | 06 Mar 2022 | |
Central Nervous System Diseases | Preclinical | US | 06 Mar 2022 |